MS for Detection of <strong>Cannabinoids</strong> 203 60. Baptista, M. J., Monsanto, P. V., Pinho Marques, E. G., et al. (2002) Hair analysis for ∆9- THC, ∆9-THC-COOH, CBN <strong>and</strong> CBD, by GC/EI-MS Comparison with GC/MS-NCI for ∆9-THC-COOH. Forensic Sci. Int. 128, 66–78. 61. Cirimele, V., Kintz, P., <strong>and</strong> Mangin, P. (1995) Testing of human hair for cannabis. Forensic Sci. Int. 70, 175–182. 62. Kintz, P., Cirimele, V., <strong>and</strong> Mangin, P. (1995) Testing human hair for cannabis. II. Identification of THC-COOH by GC/NCI-MS as a unique proof. J. Forensic Sci. 40, 619–622. 63. Cirimele, V., Sachs, H., Kintz, P., <strong>and</strong> Mangin, P. (1996) Testing human hair for cannabis. III. Rapid screening procedure for <strong>the</strong> simultaneous identification of ∆9-tetrahydrocannabinol, cannabinol, <strong>and</strong> cannabidiol. J. Anal. Toxicol. 20, 13–16. 64. Moore, C., Guzaldo, F., <strong>and</strong> Donahue, T. (2001) The determination of 11-nor- ∆9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in hair using negative ion GC/MS <strong>and</strong> high-volume injection. J. Anal. Toxicol. 25, 555–558. 65. Strano-Rossi, S. <strong>and</strong> Chiarotti, M. (1999) Solid-phase microextraction for cannabinoids analysis in hair <strong>and</strong> its possible application to o<strong>the</strong>r drugs. J. Anal. Toxicol. 23, 7–10. 66. Wilkins, D. G., Haughey, H., Cone, E. J., Huestis, M. A., Foltz, R. L., <strong>and</strong> Rollins, D. E. (1995) Quantitative analysis of THC, 11-OH-THC, <strong>and</strong> THCCOOH in human hair by negative ion chemical ionization mass spectrometry. J. Anal. Toxicol. 19, 483–491. 67. Sachs, H. <strong>and</strong> Dressler, U. (2000) Detection of THC-COOH in hair by MSD-NCI after HPLC clean-up. Forensic Sci. Int. 107, 239–247. 68. Jurado, C., Gimenez, M. P., Menendez, M., <strong>and</strong> Repetto, M. (1995) Simultaneous quantification of opiates, cocaine <strong>and</strong> cannabinoids in hair. Forensic Sci. Int. 70, 165–174. 69. Musshoff, F., Junker, H. P., Lachenmeier, D. W., Kroener, L., <strong>and</strong> Madea, B. (2002) Fully automated determination of cannabinoids in hair samples using headspace solid-phase microextraction <strong>and</strong> gas chromatography-mass spectrometry. J. Anal. Toxicol. 26, 554–560. 70. Musshoff, F., Lachenmeier, D. W., Kroener, L., <strong>and</strong> Madea, B. (2003) Automated headspace solid-phase dynamic extraction for <strong>the</strong> determination of cannabinoids in hair samples. Forensic Sci. Int. 133, 32–38. 71. Chiarotti, M. <strong>and</strong> Costamagna, L. (2000) Analysis of 11-nor-9-carboxy-∆9-tetrahydrocannabinol in biological samples by GC/MS/MS. Forensic Sci. Int. 114, 1–6. 72. Mieczkowski, T. (1995) A research note: The outcome of GC/MS/MS confirmation of hair assays on 93 cannabinoid-positive cases. Forensic Sci. Int. 70, 83–91. 73. Baker, T. S., Harry, J. V., Russell, J. W., <strong>and</strong> Myers, R .L. (1984) Rapid method for <strong>the</strong> GC/MS confirmation of 11-nor-9-carboxy-∆9-tetrahydrocannabinol in urine. J. Anal. Toxicol. 8, 255–259. 74. De Cock, K. J. S., Delbeke, F. T., De Boer, D., Van Eenoo, P., <strong>and</strong> Roels, K. (2003) Quantitation of 11-nor-∆9-tetrahydrocannabinol-9-carboxylic acid with GC/MS in urine collected for doping analysis. J. Anal. Toxicol. 27, 106–109. 75. Lisi, A. M., Kazlauskas, R., <strong>and</strong> Trout, G. J. (1993) Gas chromatographic-mass spectrometric quantitation of urinary 11-nor-∆9-tetrahydrocannabinol-9-carboxylic acid after derivatization by extractive alkylation. J. Chromatogr. 617, 265–270. 76. Foltz, R. L., McGinnis, K. M., <strong>and</strong> Chinn, D. M. (1983) Quantitative measurement of ∆9- tetrahydrocannabinol <strong>and</strong> two major metabolites in physiological specimens using capillary column gas chromatography/negative ion chemical ionization mass spectrometry. Biomed. Mass Spectrom. 10, 316–323. 77. Weller, J.-P., Wolf, M., <strong>and</strong> Szidat, S. (2000) Enhanced sensitivity in <strong>the</strong> determination of ∆9-tetrahydrocannabinol <strong>and</strong> two major metabolites in serum using ion-trap GC/MS/MS. J. Anal. Toxicol. 24, 359–364. 78. Stonebraker, W. E., Lamoreaux, T. C., Bebault, M., Rasmussen, S. A., Jepson, B. R., <strong>and</strong> Beck, B. K. (1998) Robotic solid-phase extraction <strong>and</strong> GC/MS analysis of THC in blood. Am. Clin. Lab. 17, 18–19.
204 Foltz 79. Collins, M., Easson, J., Hansen, G., Hodda, A., <strong>and</strong> Lewis, K. (1997) GC/MS/MS confirmation of unusually high ∆9-tetrahydrocannabinol levels in two postmortem blood samples. J. Anal. Toxicol. 21, 538–542. 80. Uhl, M. (1997) Determination of drugs in hair using GC/MS/MS. Forensic Sci. Int. 84, 281–294. 81. Cirimele, V., Kintz, P., Majdalani, R., <strong>and</strong> Mangin, P. (1995) Supercritical fluid extraction of drugs in drug addict hair. J. Chromatogr. B Biomed. Appl. 673, 173–181. 82. Rosenfeld, J. M., McLeod, R. A., <strong>and</strong> Foltz, R. L. (1986) Solid-supported reagents in <strong>the</strong> determination of cannabinoids in plasma. Anal. Chem. 58, 716–721.
- Page 1 and 2:
Marijuana and the Cannabinoids Edit
- Page 3 and 4:
F O R E N S I C SCIENCE AND MEDICIN
- Page 5 and 6:
© 2007 Humana Press Inc. 999 River
- Page 8 and 9:
Contents Preface ..................
- Page 10 and 11:
Contributors RUDOLF BRENNEISEN, PhD
- Page 12 and 13:
Cannabis and Natural Cannabis Medic
- Page 14 and 15:
Cannabis and Natural Cannabis Medic
- Page 16 and 17:
Cannabis and Natural Cannabis Medic
- Page 18 and 19:
Cannabis and Natural Cannabis Medic
- Page 20 and 21:
Cannabis and Natural Cannabis Medic
- Page 22 and 23:
Cannabis and Natural Cannabis Medic
- Page 24 and 25:
Cannabis and Natural Cannabis Medic
- Page 26 and 27:
Cannabis and Natural Cannabis Medic
- Page 28 and 29:
Chemistry of Cannabis Constituents
- Page 30 and 31:
Chemistry of Cannabis Constituents
- Page 32 and 33:
Chemistry of Cannabis Constituents
- Page 34 and 35:
Chemistry of Cannabis Constituents
- Page 36 and 37:
Chemistry of Cannabis Constituents
- Page 38 and 39:
Chemistry of Cannabis Constituents
- Page 40 and 41:
Chemistry of Cannabis Constituents
- Page 42 and 43:
Chemistry of Cannabis Constituents
- Page 44 and 45:
Chemistry of Cannabis Constituents
- Page 46 and 47:
Chemistry of Cannabis Constituents
- Page 48 and 49:
Chemistry of Cannabis Constituents
- Page 50 and 51:
Chemistry of Cannabis Constituents
- Page 52 and 53:
Chemistry of Cannabis Constituents
- Page 54 and 55:
Chemistry of Cannabis Constituents
- Page 56 and 57:
Chemistry of Cannabis Constituents
- Page 58 and 59:
Chemistry of Cannabis Constituents
- Page 60 and 61:
Chemistry of Cannabis Constituents
- Page 62 and 63:
Chemical Fingerprinting of Cannabis
- Page 64 and 65:
Chemical Fingerprinting of Cannabis
- Page 66 and 67:
Chemical Fingerprinting of Cannabis
- Page 68 and 69:
Chemical Fingerprinting of Cannabis
- Page 70 and 71:
Chemical Fingerprinting of Cannabis
- Page 72 and 73:
Chemical Fingerprinting of Cannabis
- Page 74 and 75:
Chemical Fingerprinting of Cannabis
- Page 76 and 77:
Chemical Fingerprinting of Cannabis
- Page 78 and 79:
Marijuana Smoke Condensate 67 Chapt
- Page 80 and 81:
Marijuana Smoke Condensate 69 Fig.
- Page 82 and 83:
Marijuana Smoke Condensate 71 fied,
- Page 84 and 85:
Marijuana Smoke Condensate 73 Table
- Page 86 and 87:
Marijuana Smoke Condensate 75 Table
- Page 88 and 89:
Marijuana Smoke Condensate 77 Table
- Page 90 and 91:
Marijuana Smoke Condensate 79 Table
- Page 92 and 93:
Marijuana Smoke Condensate 81 Table
- Page 94 and 95:
Marijuana Smoke Condensate 83 Table
- Page 96 and 97:
Marijuana Smoke Condensate 85 Table
- Page 98 and 99:
Marijuana Smoke Condensate 87 Table
- Page 100 and 101:
Marijuana Smoke Condensate 89 Table
- Page 102 and 103:
Marijuana Smoke Condensate 91 Table
- Page 104 and 105:
Marijuana Smoke Condensate 93 of th
- Page 106 and 107:
Marijuana Smoke Condensate 95 12. N
- Page 108 and 109:
Pharmacology of Cannabinoids 97 Cha
- Page 110 and 111:
Pharmacology of Cannabinoids 99 Fig
- Page 112 and 113:
Pharmacology of Cannabinoids 101 an
- Page 114 and 115:
Pharmacology of Cannabinoids 103 Fi
- Page 116 and 117:
Pharmacology of Cannabinoids 105 Fi
- Page 118 and 119:
Pharmacology of Cannabinoids 107 CB
- Page 120 and 121:
Pharmacology of Cannabinoids 109 st
- Page 122 and 123:
Pharmacology of Cannabinoids 111 Fi
- Page 124 and 125:
Pharmacology of Cannabinoids 113 ti
- Page 126 and 127:
Pharmacology of Cannabinoids 115 Fi
- Page 128 and 129:
Pharmacology of Cannabinoids 117 do
- Page 130 and 131:
Pharmacology of Cannabinoids 119 19
- Page 132 and 133:
Pharmacology of Cannabinoids 121 57
- Page 134 and 135:
Pharmacology of Cannabinoids 123 97
- Page 136 and 137:
Therapeutic Potential of Cannabinoi
- Page 138 and 139:
Therapeutic Potential of Cannabinoi
- Page 140 and 141:
Therapeutic Potential of Cannabinoi
- Page 142 and 143:
Therapeutic Potential of Cannabinoi
- Page 144 and 145:
Therapeutic Potential of Cannabinoi
- Page 146 and 147:
Therapeutic Potential of Cannabinoi
- Page 148 and 149:
Therapeutic Potential of Cannabinoi
- Page 150 and 151:
Therapeutic Potential of Cannabinoi
- Page 152 and 153:
Therapeutic Potential of Cannabinoi
- Page 154 and 155:
Therapeutic Potential of Cannabinoi
- Page 156 and 157:
Immunoassays to Detect Cannabis Abu
- Page 158 and 159:
Immunoassays to Detect Cannabis Abu
- Page 160 and 161:
Immunoassays to Detect Cannabis Abu
- Page 162 and 163:
Immunoassays to Detect Cannabis Abu
- Page 164 and 165: Immunoassays to Detect Cannabis Abu
- Page 166 and 167: Immunoassays to Detect Cannabis Abu
- Page 168 and 169: Immunoassays to Detect Cannabis Abu
- Page 170 and 171: Immunoassays to Detect Cannabis Abu
- Page 172 and 173: Immunoassays to Detect Cannabis Abu
- Page 174 and 175: Immunoassays to Detect Cannabis Abu
- Page 176 and 177: 165 Table 2 Analytical Recovery of
- Page 178 and 179: Immunoassays to Detect Cannabis Abu
- Page 180 and 181: Immunoassays to Detect Cannabis Abu
- Page 182 and 183: Immunoassays to Detect Cannabis Abu
- Page 184 and 185: Immunoassays to Detect Cannabis Abu
- Page 186 and 187: Immunoassays to Detect Cannabis Abu
- Page 188 and 189: Immunoassays to Detect Cannabis Abu
- Page 190 and 191: MS for Detection of Cannabinoids 17
- Page 192 and 193: MS for Detection of Cannabinoids 18
- Page 194 and 195: MS for Detection of Cannabinoids 18
- Page 196 and 197: MS for Detection of Cannabinoids 18
- Page 198 and 199: MS for Detection of Cannabinoids 18
- Page 200 and 201: 189 Table 1 Published Methods for M
- Page 202 and 203: 191 30 THCA SPE No derivatization L
- Page 204 and 205: 193 Table 3 Published Methods for M
- Page 206 and 207: 195 Table 5 Published Methods for M
- Page 208 and 209: 197 Table 7 Published Methods for M
- Page 210 and 211: MS for Detection of Cannabinoids 19
- Page 212 and 213: MS for Detection of Cannabinoids 20
- Page 216 and 217: Human Cannabinoid Pharmacokinetics
- Page 218 and 219: Human Cannabinoid Pharmacokinetics
- Page 220 and 221: Human Cannabinoid Pharmacokinetics
- Page 222 and 223: Human Cannabinoid Pharmacokinetics
- Page 224 and 225: Human Cannabinoid Pharmacokinetics
- Page 226 and 227: Human Cannabinoid Pharmacokinetics
- Page 228 and 229: Human Cannabinoid Pharmacokinetics
- Page 230 and 231: Human Cannabinoid Pharmacokinetics
- Page 232 and 233: Human Cannabinoid Pharmacokinetics
- Page 234 and 235: Human Cannabinoid Pharmacokinetics
- Page 236 and 237: Human Cannabinoid Pharmacokinetics
- Page 238 and 239: Human Cannabinoid Pharmacokinetics
- Page 240 and 241: Human Cannabinoid Pharmacokinetics
- Page 242 and 243: Human Cannabinoid Pharmacokinetics
- Page 244 and 245: Human Cannabinoid Pharmacokinetics
- Page 246 and 247: Human Cannabinoid Pharmacokinetics
- Page 248 and 249: Medical and Health Consequences of
- Page 250 and 251: Medical and Health Consequences of
- Page 252 and 253: Medical and Health Consequences of
- Page 254 and 255: Medical and Health Consequences of
- Page 256 and 257: Medical and Health Consequences of
- Page 258 and 259: Medical and Health Consequences of
- Page 260 and 261: Medical and Health Consequences of
- Page 262 and 263: Medical and Health Consequences of
- Page 264 and 265:
Effects of Marijuana on Immune Defe
- Page 266 and 267:
Effects of Marijuana on Immune Defe
- Page 268 and 269:
Effects of Marijuana on Immune Defe
- Page 270 and 271:
Effects of Marijuana on Immune Defe
- Page 272 and 273:
Effects of Marijuana on Immune Defe
- Page 274 and 275:
Effects of Marijuana on Immune Defe
- Page 276 and 277:
Effects of Marijuana on Immune Defe
- Page 278 and 279:
Effects of Marijuana on Immune Defe
- Page 280 and 281:
Effects of Marijuana on Immune Defe
- Page 282 and 283:
Effects of Marijuana on Immune Defe
- Page 284 and 285:
Effects of Marijuana on Immune Defe
- Page 286 and 287:
Effects of Marijuana on Immune Defe
- Page 288 and 289:
Marijuana and Driving Impairment 27
- Page 290 and 291:
Marijuana and Driving Impairment 27
- Page 292 and 293:
Marijuana and Driving Impairment 28
- Page 294 and 295:
Marijuana and Driving Impairment 28
- Page 296 and 297:
Marijuana and Driving Impairment 28
- Page 298 and 299:
Marijuana and Driving Impairment 28
- Page 300 and 301:
Marijuana and Driving Impairment 28
- Page 302 and 303:
Marijuana and Driving Impairment 29
- Page 304 and 305:
Marijuana and Driving Impairment 29
- Page 306 and 307:
Postmortem Considerations 295 Chapt
- Page 308 and 309:
Postmortem Considerations 297 vascu
- Page 310 and 311:
Postmortem Considerations 299 where
- Page 312 and 313:
Postmortem Considerations 301 18. B
- Page 314 and 315:
Cannabinoid Effects on Mental Proce
- Page 316 and 317:
Cannabinoid Effects on Mental Proce
- Page 318 and 319:
Cannabinoid Effects on Mental Proce
- Page 320 and 321:
Cannabinoid Effects on Mental Proce
- Page 322 and 323:
Cannabinoid Effects on Mental Proce
- Page 324 and 325:
Cannabinoid Effects on Mental Proce
- Page 326:
Cannabinoid Effects on Mental Proce
- Page 329 and 330:
318 Index THC, 283, 284 THC/11-carb
- Page 331 and 332:
320 Index Immune system, cannabinoi
- Page 333:
322 Index ∆9-Tetrahydrocannabinol